
Welcome
Welcome to the website of the CellCOM Research Group. Our group is a translational and clinical research group within the Center for Research in Nanomaterials and Biomedicine (CINBIO). Our approaches combine in vitro, ex vivo and in vivo models to conduct pre-clinical studies in age-related diseases and cancer. Our group is a multidisciplinary team that includes basic scientists (predoctoral, postdoctoral fellows and technicians) and clinical researchers such as pathologists, dermatologists, radiologists and surgeons.
Our aims are to understand the physiopathology of connexin-linked diseases (cancer, inflammation, tissue degeneration), to design molecules and new drugs that modulate the activity of specific targets and to identify novel markers of disease prevention, diagnosis and disease management.
We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, metastasis and resistance to targeted cancer therapies and immunotherapies. Our final goal is to identify effective therapeutic targets to design specific and successful therapeutic approaches to treat these disorders.
Follow us on Twitter to stay updated on news
Latest news
VIII International Young Investigator Meeting
Dic 2017 VIII International Young Investigator Meeting INIBIC, UDC, USC and MUNCYT…
New paper published in Ageing Research Reviews
Dic 2017 This research was performed in collaboration with Manuel Collado…
Consolidated Group A into INIBIC scientific structure
March 2017 Consolidated Group A into INIBIC scientific structure The CellCOM…
New postdoctoral fellow
Oct 2017 Thanks to Fundación Alfonso Martín Escudero, Samasta Gasco Cavero…
Science Xpression 2017 «Gap Junctions and Hemichannels: Physiological and Pathological Roles»
Sept 2017 Science Xpression Workshop Gap Junctions and Hemichannels: Physiological and…
Keynote Speaker at International Gap Junction Conference
Aug 2017 María D. Mayán will participate as keynote speaker at…